(Q46476206)

English

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

scientific article published on 10 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

1 reference

based on heuristic

inferred from title

1

object named as

Yukio Homma

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

author name string

Takuhiro Yamaguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

Osamu Yamaguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

publication date

10 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

15

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

809-815

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

An epidemiological survey of overactive bladder symptoms in Japan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Pathophysiology of the overactive bladder and its pharmacological treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Pharmacological effects of KRP-197 on the human isolated urinary bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Clinical efficacy and tolerability of extended‐release tolterodine and immediate‐release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo‐controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Antimuscarinics for treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02104.X

21 January 2018

Identifiers

10.1111/J.1442-2042.2008.02104.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18637156

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46476206&oldid=2113243342"